Ignite Creation Date:
2025-12-24 @ 9:06 PM
Ignite Modification Date:
2026-03-28 @ 7:20 AM
Study NCT ID:
NCT00288704
Status:
COMPLETED
Last Update Posted:
2011-12-06
First Post:
2006-02-06
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Rilonacept for Treatment of Cryopyrin-Associated Periodic Syndromes (CAPS)
Sponsor:
Regeneron Pharmaceuticals
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
IL1T-AI-0505
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None